University of Iowa-Children's Hospital
Iowa City, Iowa 52242-1083
4 studies enrolling now · 42 studies all time
What they study most
Acute Kidney Injury in Pediatric Patients, Adolescent Idiopathic Scoliosis, Atrial Arrhythmia, Atrial Tachycardia, Breastfeeding Duration, Congenital Heart Disease, Constipation - Functional, Cystic Fibrosis, Diabetes Mellitus, Type 1, Donor Milk Supplementation, Dravet Syndrome, Duchenne Muscular Dystrophy
Studies at this site
- ATrial Tachycardia PAcing Therapy in Congenital Heart — Recruiting now
- Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study — Recruiting now
- National Collaborative to Improve Care of Children With Complex Congenital Heart Disease — Recruiting now
- Study of Ataluren in Previously Treated Participants With Nonsense Mutation Dystrophinopathy (nmDBMD) — Completed
- Bracing in Adolescent Idiopathic Scoliosis Trial (BrAIST) — Stopped early
- A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity — Completed
- A Long-Term Study of Bivamelagon in Participants With Hypothalamic Obesity (HO) — Enrolling by invitation
- An Open-Label Extension Study of STK-001 for Patients With Dravet Syndrome — Running, not enrolling
- Study of SRP-4045 (Casimersen) and SRP-4053 (Golodirsen) in Participants With Duchenne Muscular Dystrophy (DMD) — Completed
- Prismaflex HF20 Set and Prismaflex® System 7.10/7.20 for Acute Continuous Renal Replacement Therapy (CRRT) in Children — Stopped early
- Randomized, Double-Blind, Safety and Efficacy Study of RE-021 (Sparsentan) in Focal Segmental Glomerulosclerosis — Completed
- Safety, Tolerability and Efficacy of ACTIMMUNE® Dose Escalation in Friedreich's Ataxia Study — Completed
- Safety, Tolerability and Efficacy of ACTIMMUNE® Dose Escalation in Friedreich's Ataxia — Completed
- Long-Term Safety Extension Study of ACTIMMUNE® (Interferon γ-1b) in Children and Young Adults With Friedreich's Ataxia — Completed
- An Extension Study to Evaluate Casimersen or Golodirsen in Patients With Duchenne Muscular Dystrophy — Stopped early
- Protege Encore Study- Clinical Trial of Teplizumab (MGA031) in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus — Stopped early
- The Protégé Study - Clinical Trial of MGA031 in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus — Completed
- Evaluate Safety and Biological Activity of ATYR1940 in Participants With Early Onset Facioscapulohumeral Muscular Dystrophy — Completed
- Low Dose Oral Methotrexate in Pediatric Crohn's Disease Patients Initiating Anti-Tumor Necrosis Factor (Anti-TNF) Therapy — Completed
- Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Duchenne Muscular Dystrophy — Completed
- Phase III Study of Edasalonexent in Boys With Duchenne Muscular Dystrophy — Completed
- A Study to Evaluate Efficacy of rFVIIIFc for Immune Tolerance Induction (ITI) in Severe Hemophilia A Participants With Inhibitors Undergoing the First ITI Treatment (verITI-8 Study) — Completed
- Efficacy, Tolerability, and Pharmacokinetics of Multiple Doses of Oral TAK-831 in Adults With Friedreich Ataxia — Completed
- Safety and Pharmacology Study of VP 20629 in Adults With Friedreich's Ataxia — Completed
- Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy — Completed
- Study of Eteplirsen in DMD Patients — Completed
- An Open-Label Extension Study of Edasalonexent in Boys With Duchenne Muscular Dystrophy — Stopped early
- Lubiprostone in Children With Functional Constipation — Completed
- Safety Study of Eteplirsen to Treat Advanced Stage Duchenne Muscular Dystrophy — Completed
- Lubiprostone for Children With Constipation — Completed
- A Research Trial of Aralast in New Onset Diabetes (RETAIN) — Stopped early
- Rx Milk Study of Donor Milk Supplementation to Improve Breastfeeding Outcomes — Completed
- Smartphone Ophthalmoscope of Lens Vascularity to Estimate Gestational Age — Completed
- IGIV Study for Chronic ITP Patients Ages 3-70 — Completed
- Efficacy and Safety of Gastric Suctioning During Neonatal Resuscitation — Stopped early
- Study of Cavosonstat (N91115) in Patients With CF Homozygous for the F508del-CFTR Mutation — Completed
- Study of N91115 in Patients With Cystic Fibrosis Homozygous F508del-CFTR Mutation — Completed
- Evaluation of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC) — Completed
- Evaluation of Repeat Administration of Purified Poloxamer 188 — Completed
- Patient Plasma Response and Outcome in Septic Shock With Thrombocytopenia Associated Multiple Organ Failure in Children — Completed
- Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature — Completed
- Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation — Completed